Saint Herblain (France), November 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the U.S ...

(WJW) — A popular anxiety drug is being recalled over a ‘life-threatening’ label mistake. In a recall alert for some lots of Clonazepam Orally Disintegrating Tablets the FDA states the ...

The application also includes adding the two-year antibody persistence data to the product label, which is a key differentiator for IXCHIQ ®. This FDA application follows the submission of label ...

Ryan Roslansky, the CEO of Microsoft-owned LinkedIN. A recent case study highlights the challenges LinkedIN encountered as it tried to figure out how best to display data from C2PA content ...

A deadly car crash involving an Instagram model. Many Americans have only recently learned of the drug known as "pink cocaine" from a deluge of celebrity horror stories. Joseph Palamar ...

He also wants to end what he calls the [Food and Drug Administration’s], quote, “war on public health,” which includes regulation of raw milk and some unproven stem cell treatments.

President-elect Donald Trump announced Friday that he has picked Dr. Martin Makary, a Johns Hopkins surgeon as Food and Drug Administration commissioner. “FDA has lost the trust of Americans and ...

After years of analysis, the reports and new scientific research led the FDA in 2020 to add a “black box” warning to the montelukast prescribing label, flagging serious mental health risks ...

Advisers to Robert F. Kennedy Jr. are weighing a significant rewrite to the Food and Drug Administration's rules governing food additives, to fulfill Kennedy and President-elect Donald Trump's ...

(Jonny Hodder/CBC) The presence of a highly toxic synthetic opioid in Newfoundland and Labrador has drug safety advocates sounding the alarm over the deadly substance. Earlier this week ...

Renu Lal, Pharm.D., is Scientist, Genentech, Inc.; when this article was written she was Team Leader, Division of Drug Information, Office of Training and Communications, Center for Drug ...

11 at 4:30 p.m. EST to discuss further details, according to a news release. Potential Ziihera patients may have their cancer identified using the PATHWAY HER2 (4B5) test, now approved under an FDA ...